£15k/month Health Anxiety App - Should They Take Investment or Stay Bootstrapped?
by
Get the full episode insights!
Enter your email below to get notified about more insights from:
James Sinclair's Business Broadcast
This episode is titled:
£15k/month Health Anxiety App - Should They Take Investment or Stay Bootstrapped?
Notable Quotes
"We're aiming for a million in revenue and our first NHS pilot."
"Building user trust and community is vital for long-term success."
Get episode summaries just like this for all your favourite podcasts in your inbox every day!
Get More InsightsEpisode Summary
In this episode of the Business Broadcast, host James Sinclair chats with Joseph Newton, co-founder of Conjury App, a startup launched just two years ago that addresses health anxiety. The app has impressively reached £15,000 in monthly revenue, propelled by organic growth from TikTok marketing. Joseph shares insights into the challenges they face, including deciding when to engage with the NHS for partnerships, the possibility of integrating telehealth services, and whether to pursue debt or equity for funding. He aims for a million in revenue and a pilot with the NHS within a year, while also dreaming of a multi-nine-figure exit. Joseph emphasizes the importance of building their user base and marketing efforts while remaining cautious about bringing in external funding too early, as it could dilute their control over the business. The discussion touches on strategic growth through content marketing and the nuances of launching healthcare tech.
Key Takeaways
- Leveraging social media can accelerate business growth.
- Prioritize customer acquisition over immediate profit when scaling.
Found an issue with this summary?
Log in to Report IssueMore Podcast Insights
Today in Focus
US-Iran ceasefire: has Tehran played Trump? – The Latest
Apr 8, 2026
RunPod
RunPod Sprint! Megan Boxall
Apr 8, 2026
Entrepreneur Conversations
This will transform your business...
Apr 8, 2026
Eventful Lives
FOUNDER #19. British Entrepreneur's £4 Billion Exit - Richard Harpin
Apr 8, 2026